California BioResearch Product Faire™
UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.Read More
Tags: CA, Current Biotechnology Events, immunotherapy, Stem cell research, Human Stem Cell, California, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, BioResearch Product Faire, Bioresearch Grant, Laboratory product sales, laboratory tools
UC Davis Medical Center’s Mind Institute was one of five institutes in the nation to win the NIH’s Autism Centers of Excellence Award (ACE). The $12 million, five year grant, will be used for the creation of the “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.” This new center will take a personalize approach to addressing autism spectrum disorder (ASD) treatment based on a child’s behavioral and biological characteristics. The goal will be to identify and tailor treatments that improve the quality of life for those with ASD.Read More
Tags: CA, Current Biotechnology Events, California, NIH funded Research Projects, Autism, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, drug evaluation, BioResearch Product Faire, autism research, Bioresearch Grant, Laboratory product sales, NIH awards 2017
A $1M grant from the National Science Foundation, funds the Center for Biophotonic Sensors & Systems (CBSS) for future study on biosensors. This is a multi-site program between Boston University Photonics Center and the Center for Biophotonics Science and Technology at UC Davis.
Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.Read More
Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
UC Davis Medical Center researchers have recently been awarded several grants to investigate promising treatments for Angleman Syndrome. Dr. David Segal, professor in the Department of Biochemistry and Molecular Medicine, has received over $1.2 million from the Foundation for Angelman Syndrome Therapeutics (FAST) to develop a potential treatment. Joe Anderson, PhD, assistant adjunct professor in the Department of Internal Medicine, received $500,000 from the same organization to pursue a different approach to developing a treatment for the genetic disorder. The university also received a $1.1 million grant from the California Institute for Regenerative Medicine (CIRM) in July, which brings the total for Angelman Syndrome grant funding to nearly $3 million. This puts UC Davis at the forefront of research into the disorder.
(Image of UBE3A Protien courtesy of Wikimedia Commons)Read More
(Article posted 2015 and updated in 2016)
Patients with a condition known as lung nodules may soon be breathing a bit more easily, thanks to research funding granted to the University of California, Davis and a new diagnostic technology tested in a 2016 study at the Morehouse School of Medicine and Emory University. Lung nodules are usually benign, small lesions often found in CT chest scans. While only 2% of these nodules end up being cancerous, they still require examination and monitoring to ensure the safety of the patient.Read More
Tags: CA, Emory University, University of California Davis, cancer research, California, Cancer, UCDMC, BioResearch Product Faire Event, Research Funding, Sacramento, Davis, UC Davis - Medical Center, research grants, lung cancer
UC Davis Professor Kit Lam has been awarded two separate federal grants to further his cancer research. The first grant is from the National Institute of Biomedical Imaging and Bioengineering. This 4-year, $2 million grant will fund research on the use of targeted nanotheraputics against oral cancer. The second grant is from the National Cancer Institute. This 3-year, $1.2 million research grant will be used to explore new technology for functional imaging in living cells.Read More
(Original article from 2013 by Jennifer Niuwkerk. Updated information added by Jennifer Winstead.)
Are you a researcher, lab manager, post-doc or purchasing agent interested in networking with colleagues and learning about the latest lab equipment and services on the market at the Universtity of California, Davis Medical Center?
UPDATE: If so, make sure you don’t miss Biotechnology Calendar, Inc.’s Sacramento BioResearch Product Faire™ Event on June 7, 2016. Lab supply companies are eager to meet researchers at this event and discuss with you your research goals. If you are facing problems in the lab, the sales reps at our UC Davis Medical Center show may be able to recommend viable life science solutions.
An estimated 30,000 people in the United States are afflicted with Huntington’s disease. Receiving a diagnosis of this genetic neurodegenerative disorder is unimaginably devastating. Sufferers slowly lose control of their movement and develop psychiatric problems over the course of 10-25 years, and often the disease is undetected until adulthood. Just this year, UC Davis researchers in Sacramento, California have discovered that human mesenchymal stem cells (MSCs) - cells with the ability to differentiate into bone cells, muscle cells, and other cell types - could be the key to developing an effective new therapy to treat Huntington’s. The promising findings are published in the journal Molecular Therapy.Read More